Testing SRSD216 for people with high lipoprotein (a)
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to sign a consent form and follow study rules.
- You can be any gender or race.
- Your body mass index (BMI) must be between 18 and 40.
- Men cannot donate sperm and women cannot donate eggs during the study and for 3 months after.
- You should not have a history of bleeding problems or blood clots.
- You should not have had cancer (except some minor skin or localized cancers) in the last 3 years.
- You should not have a fever or active infection within the last week before treatment.
- You should not have had major surgery in the last 3 months or plan one during the study.
- You should not have a known allergy to similar drugs.
- Your fasting triglycerides (a type of fat) should be below 500 mg/dL.
- You should not have taken another experimental drug in the last 30 days (or 5 half-lives).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study tests a new medicine called SRSD107 for people with long-term blockages in heart or leg arteries. It aims to see if the drug can help prevent clots safely.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Hear when a new Hyperlipoproteinemia (a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.